Zoricic, I
Throughout the study, safety assessments included physical examinations, vital sign measurements, electrocardiograms, laboratory testing, adverse event monitoring, and the administration of the Beck Scale for Suicidal Ideation
Third, there is mounting evidence that GLP-1RA therapy in patients with obesity and/or type 2 diabetes has cardiovascular (142, 143), renal (144), hepatic (145), and mortality benefits that are partially independent of weight loss (146)
During the consultation, the provider asks additional questions and discusses your goals
Longer-term follow-up data from the SUSTAIN trial series revealed that continuous GLP-1 therapy maintains weight loss durably
Some programs offer coaching and nutrition tools, while others focus only on medication access